Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Bellevue, WA
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated:  4/10/2017
Research Site
mi
from
Antofagasta,
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Status: Enrolling
Updated: 4/10/2017
Research Site
mi
from
Antofagasta,
Click here to add this to my saved trials
Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring
Transcranial Magnetic Stimulation in Major Depression With EEG and NIRS Monitoring
Status: Enrolling
Updated:  4/19/2017
Boston Med Ctr
mi
from
Boston, MA
Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring
Transcranial Magnetic Stimulation in Major Depression With EEG and NIRS Monitoring
Status: Enrolling
Updated: 4/19/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis
Status: Enrolling
Updated:  4/24/2017
University of Arizona
mi
from
Tucson, AZ
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis
Status: Enrolling
Updated: 4/24/2017
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
Status: Enrolling
Updated:  4/24/2017
University of Arizona Department of Psychiatry
mi
from
Tucson, AZ
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
Status: Enrolling
Updated: 4/24/2017
University of Arizona Department of Psychiatry
mi
from
Tucson, AZ
Click here to add this to my saved trials
Social Cognition in Longstanding Psychosis
Social Cognition in Longstanding Psychosis
Status: Enrolling
Updated:  4/24/2017
University of Arizona Department of Psychiatry
mi
from
Tucson, AZ
Social Cognition in Longstanding Psychosis
Social Cognition in Longstanding Psychosis
Status: Enrolling
Updated: 4/24/2017
University of Arizona Department of Psychiatry
mi
from
Tucson, AZ
Click here to add this to my saved trials
Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Supplemental TMS vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Status: Enrolling
Updated:  4/24/2017
Sheppard Pratt Health System
mi
from
Towson, MD
Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Supplemental TMS vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Status: Enrolling
Updated: 4/24/2017
Sheppard Pratt Health System
mi
from
Towson, MD
Click here to add this to my saved trials
Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis
Pharmacogenetic Testing in an Outpatient Population of Patients With Major Depressive Disorder or Depressive Disorder Not Otherwise Specified With Avera Medical Group Clinics
Status: Enrolling
Updated:  5/2/2017
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis
Pharmacogenetic Testing in an Outpatient Population of Patients With Major Depressive Disorder or Depressive Disorder Not Otherwise Specified With Avera Medical Group Clinics
Status: Enrolling
Updated: 5/2/2017
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
Status: Enrolling
Updated:  5/2/2017
Avera Institute for Human Genetics
mi
from
Sioux Falls, SD
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
Status: Enrolling
Updated: 5/2/2017
Avera Institute for Human Genetics
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major Depression
Comparison of Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopy (MRS) as Bioenergetic Imaging Modalities in Healthy Human Brain and Major Depressive Disorder
Status: Enrolling
Updated:  5/18/2017
University of Utah Dept of Psychiatry
mi
from
Salt Lake City, UT
Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major Depression
Comparison of Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopy (MRS) as Bioenergetic Imaging Modalities in Healthy Human Brain and Major Depressive Disorder
Status: Enrolling
Updated: 5/18/2017
University of Utah Dept of Psychiatry
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases
Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases
Status: Enrolling
Updated:  7/21/2017
Laureate Institute for Brain Research
mi
from
Tulsa, OK
Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases
Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases
Status: Enrolling
Updated: 7/21/2017
Laureate Institute for Brain Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Ketamine in the Treatment of Suicidal Depression
Ketamine vs. Midazolam: Testing Rapid Relief of Suicide Risk in Depression
Status: Enrolling
Updated:  8/24/2017
Columbia University/New York State Psychiatric Institute
mi
from
New York, NY
Ketamine in the Treatment of Suicidal Depression
Ketamine vs. Midazolam: Testing Rapid Relief of Suicide Risk in Depression
Status: Enrolling
Updated: 8/24/2017
Columbia University/New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
The Neurobiology of Approach Avoidance Training in Depression
The Neurobiology of Approach Avoidance Training in Depression
Status: Enrolling
Updated:  8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
The Neurobiology of Approach Avoidance Training in Depression
The Neurobiology of Approach Avoidance Training in Depression
Status: Enrolling
Updated: 8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated:  9/5/2017
New York State Psychiatric Institute
mi
from
New York, NY
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated: 9/5/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated:  9/5/2017
University of Ottawa, Institute of Mental Health Research
mi
from
Ottawa,
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated: 9/5/2017
University of Ottawa, Institute of Mental Health Research
mi
from
Ottawa,
Click here to add this to my saved trials
Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
A Pathophysiological Study to Determine if Enhancing Glutamate Transporter Function Produces Antidepressant Effects in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
A Pathophysiological Study to Determine if Enhancing Glutamate Transporter Function Produces Antidepressant Effects in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Phoenix, AZ
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Little Rock, AR
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Orange, CA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Denver, CO
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Norwich, CT
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Norwich, CT
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Jacksonville, FL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Orlando, FL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Winter Park, FL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Springfield, IL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Springfield, IL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Rockville, MD
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Weymouth, MA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Weymouth, MA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Willingboro, NJ
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Willingboro, NJ
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Brooklyn, NY
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Dayton, OH
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Garfield Heights, OH
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Portland, OR
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Salem, OR
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Salem, OR
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Emmaus, PA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Emmaus, PA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Philadelphia, PA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Columbia, SC
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Austin, TX
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Dallas, TX
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
San Antonio, TX
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Charlottesville, VA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Milwaukee, WI
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Penticton,
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Penticton,
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Saint Charles, MO
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Status: Enrolling
Updated:  9/18/2017
New York State Psychiatric Institute
mi
from
New York, NY
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Status: Enrolling
Updated: 9/18/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Pharmacology Research Institute (PRI)
mi
from
Newport Beach, CA
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Pharmacology Research Institute (PRI)
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
The Medical Research Network, LLC
mi
from
New York, NY
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Fingerlakes Clinical Research
mi
from
Rochester, NY
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Fingerlakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials